Biofrontera Inc.
BFRI
Rank in Stocks
#31548
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization... Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.
Share Price
$0.8232
Last synced: 2026-10-16
Market Cap
$12.23M
Change (1 day)
-2.82%
Change (1 year)
-72.10%
Country
US
Trade Biofrontera Inc. (BFRI)
Category
Healthcare
Number of shares outstanding for Biofrontera Inc. (BFRI)
Number of shares outstanding as of October 2026: 0
According to Biofrontera Inc. latest financial reports and stock price the company's current number of shares outstanding is 0. At the end of October 2026 the company had 0 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Biofrontera Inc. (BFRI) from 2026 to 2026
Shares Outstanding at the end of each year
| Year | Shares Outstanding | Change |
|---|---|---|
| Not enough data for the provided dates. | ||
Shares Outstanding for similar companies or competitors
| Company | Shares Outstanding | Difference | Country |
|---|---|---|---|
| 445.06M | - |
US
|
|
| - | - |
SE
|
|
| - | - |
FR
|
|
| - | - |
IT
|
|
| 105.38M | - |
US
|
